CoChat

A Clinical Scale to Assess Benzodiazepine Withdrawal

BUSTO, USOA E., SYKORA, KATHY, SELLERS, EDWARD M. · 1989 · Journal of Clinical Psychopharmacology

The DOI matches its Crossref record.

Abstract

The objective, sensitive, and reliable quantitation of withdrawal symptoms is essential to assess physical dependence on drugs. Data collected from 23 patients abusing high doses of benzodiazepines (mean diazepam dose equivalents, 150 mg/day; range, 40–500) and from 40 long-term therapeutic users randomized to receive either placebo (N = 19) or diazepam (N = 21; mean diazepam dose equivalents, 15 mg/day; range, 5–40; mean duration of use, 72 months; range, 6–240) were analyzed. Information on the type and severity of symptoms was obtained from several assessment instruments. In the high-dose abuse group, plasma benzodiazepine concentrations were measured daily and the 3 consecutive days of greatest relative daily fall were considered the critical withdrawal period. Selection of the 22 items of the Clinical Institute Withdrawal Assessment-Benzodiazepines (CIWA-B) was based on statistically significant differences between baseline and critical withdrawal periods in high-dose subjects and between symptoms associated with placebo and diazepam in low-dose subjects, using contingency tables and logistic regression analysis. Of the 104 symptoms measured by the assessment instruments, 22 symptoms were found to distinguish withdrawal from prewithdrawal. These symptoms were selected based on significant differences (t-test, p ranged between <0.05 and <0.001) on type and severity of symptoms between baseline and the clinical withdrawal period in high-dose subjects, and on differences (cH2: P ranged between <0.05 and <0.001) in type of symptoms in placebo and diazepam subjects during the first week of withdrawal among the longterm therapeutic users of benzodiazepines. From these 22 symptoms, we constructed the CIWA-B, a scale of 20 five-point items and two additional values. We propose the CIWA-B as an instrument to assess and monitor benzodiazepine-like withdrawal.

Overview

Integrity signals

Registry

Crossref · 10.1097/00004714-198912000-00005

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 140

Metadata

Authors
BUSTO, U. E., SYKORA, K., & SELLERS, E. M.
Affiliations
University of Toronto (CA)
Venue
Journal of Clinical Psychopharmacology
Published
1989-12
Volume
9
Issue
6
Pages
412???416
ISSN
0271-0749 (ISSN-L)
OpenAlex
W1990397462
Cited by
125
References
0
Citations by year
2026: 13 · 2025: 4 · 2024: 6 · 2023: 3 · 2022: 9 · 2021: 7 · 2020: 8 · 2019: 4 · 2018: 3 · 2016: 4 · 2015: 2 · 2014: 6 · 2013: 1 · 2012: 4
FWCI
2.59
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
benzodiazepine withdrawal, benzodiazepine dependence, diazepam, withdrawal time, scale development
MeSH terms
Adult, Arousal, Benzodiazepines, Dose-Response Relationship, Drug, Humans, Long-Term Care, Middle Aged, Psychiatric Status Rating Scales, Psychometrics, Retrospective Studies, Sleep Stages, Substance Withdrawal Syndrome, Anti-Anxiety Agents, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Clinical Scale to Assess Benzodiazepine Withdrawal. https://app.cochat.ai/papers/10.1097/00004714-198912000-00005
The paper
BUSTO, U. E., SYKORA, K., & SELLERS, E. M. (1989). A Clinical Scale to Assess Benzodiazepine Withdrawal. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-198912000-00005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.